Cargando…
Long-Term Follow-Up after Intravenous Immunoglobulin Therapy in Patients with Severe Ocular Mucous Membrane Pemphigoid Unresponsive to Conventional Therapy
Mucous membrane pemphigoid (MMP) is a heterogeneous group of rare, systemic, autoimmune subepidermal inflammatory disease that affects mucous membranes and the eye. In its most severe forms, this disease needs systemic therapy, usually based on steroids and immunosuppressant agents. In unresponsive...
Autores principales: | Leuci, Stefania, Amato, Massimo, Calabria, Elena, Piscopo, Raffaele, Tranfa, Fausto, Spagnuolo, Gianrico, Mignogna, Michele Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6169236/ https://www.ncbi.nlm.nih.gov/pubmed/30327726 http://dx.doi.org/10.1155/2018/8372146 |
Ejemplares similares
-
The role of intravenous immunoglobulin in treatment of mucous membrane pemphigoid: A review of literature
por: Tavakolpour, Soheil
Publicado: (2016) -
Pemphigoid gestationis and intravenous immunoglobulin therapy()
por: Yang, Anes, et al.
Publicado: (2018) -
Tofacitinib for refractory ocular mucous membrane pemphigoid
por: James, Hayley, et al.
Publicado: (2021) -
Gut Dysbiosis in Ocular Mucous Membrane Pemphigoid
por: Low, Liying, et al.
Publicado: (2022) -
Screening Projects for Oral Carcinoma in Relation to Health Education and Patients’ Compliance: Study on 600 Participants
por: Leuci, Stefania, et al.
Publicado: (2017)